Genertec Universal Medical Group Company Limited (5UM) - Total Assets
Based on the latest financial reports, Genertec Universal Medical Group Company Limited (5UM) holds total assets worth €85.72 Billion EUR (≈ $100.21 Billion USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See 5UM book value for net asset value and shareholders' equity analysis.
Genertec Universal Medical Group Company Limited - Total Assets Trend (2016–2024)
This chart illustrates how Genertec Universal Medical Group Company Limited's total assets have evolved over time, based on quarterly financial data.
Genertec Universal Medical Group Company Limited - Asset Composition Analysis
Current Asset Composition (December 2024)
Genertec Universal Medical Group Company Limited's total assets of €85.72 Billion consist of 38.5% current assets and 61.6% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 2.8% |
| Accounts Receivable | €28.50 Billion | 33.1% |
| Inventory | €506.79 Million | 0.6% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €303.79 Million | 0.4% |
| Goodwill | €381.00 Million | 0.4% |
Asset Composition Trend (2016–2024)
This chart illustrates how Genertec Universal Medical Group Company Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Genertec Universal Medical Group Company market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Genertec Universal Medical Group Company Limited's current assets represent 38.5% of total assets in 2024, a decrease from 99.2% in 2016.
- Cash Position: Cash and equivalents constituted 2.8% of total assets in 2024, down from 4.4% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2016.
- Asset Diversification: The largest asset category is accounts receivable at 33.1% of total assets.
Genertec Universal Medical Group Company Limited Competitors by Total Assets
Key competitors of Genertec Universal Medical Group Company Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Amigo Holdings PLC
LSE:AMGO
|
UK | GBX39.20 Million |
|
SBI Cards and Payment Services Limited
NSE:SBICARD
|
India | Rs673.65 Billion |
|
Western Union Co
NYSE:WU
|
USA | $7.78 Billion |
|
IIFL Finance Limited
NSE:IIFL
|
India | Rs813.42 Billion |
|
AEON Thana Sinsap (Thailand) Public Company Limited
BK:AEONTS
|
Thailand | ฿92.25 Billion |
|
Pepper Money Ltd
AU:PPM
|
Australia | AU$17.15 Billion |
|
Menif Financial Services Ltd
TA:MNIF
|
Israel | ILA3.82 Billion |
|
General Accident PLC
LSE:GACA
|
UK | GBX14.16 Billion |
Genertec Universal Medical Group Company Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.33 | 1.36 | 3.03 |
| Quick Ratio | 1.31 | 1.34 | 3.02 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €9.22 Billion | €9.13 Billion | €36.95 Billion |
Genertec Universal Medical Group Company Limited - Advanced Valuation Insights
This section examines the relationship between Genertec Universal Medical Group Company Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.59 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | 7.1% |
| Total Assets | €86.03 Billion |
| Market Capitalization | $1.41 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Genertec Universal Medical Group Company Limited's assets below their book value (0.02x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Genertec Universal Medical Group Company Limited's assets grew by 7.1% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Genertec Universal Medical Group Company Limited (2016–2024)
The table below shows the annual total assets of Genertec Universal Medical Group Company Limited from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €86.03 Billion ≈ $100.58 Billion |
+7.08% |
| 2023-12-31 | €80.34 Billion ≈ $93.93 Billion |
+4.52% |
| 2022-12-31 | €76.87 Billion ≈ $89.87 Billion |
+9.97% |
| 2021-12-31 | €69.90 Billion ≈ $81.72 Billion |
+13.64% |
| 2020-12-31 | €61.51 Billion ≈ $71.91 Billion |
+6.32% |
| 2019-12-31 | €57.85 Billion ≈ $67.64 Billion |
+22.42% |
| 2018-12-31 | €47.26 Billion ≈ $55.25 Billion |
+25.24% |
| 2017-12-31 | €37.73 Billion ≈ $44.11 Billion |
+30.27% |
| 2016-12-31 | €28.96 Billion ≈ $33.86 Billion |
-- |
About Genertec Universal Medical Group Company Limited
Genertec Universal Medical Group Company Limited, together with its subsidiaries, provides financing, advisory, and medical services in the People's Republic of China. It operates through two segments, Finance Business and Healthcare Business. The Finance Business segment offers direct finance leasing; sale and leaseback; accounts receivable factoring; operating leases; and advisory services. Its… Read more